Tom Teerlink

12.5k citations
242 papers · 10.1k indexed · h-index 55

Tom Teerlink

241 papers receiving 9.8k citations

Peers

Tom Teerlink
Comparison fields: 5 of 150
  • Clinical Biochemistry 1.1k
  • Physiology 3.2k
  • Nephrology 804
  • Biochemistry 804
  • Endocrinology, Diabetes and Metabolism 1.6k
Replace Subramaniam Pennathur with:
Subramaniam Pennathur United States
Erwin Schleicher Germany
Hua Cai United States
Eiichi Araki Japan
Hiroshi Maegawa Japan
Jerry L. Nadler United States
Stefanie M. Bode‐Böger Germany
Atsunori Kashiwagi Japan
Edzard Schwedhelm Germany
Ryuzo Kawamori Japan
Tom Teerlink relative to Subramaniam Pennathur United States Subramaniam Pennathur's profile →
Citations per field
00.5×1.5×
Subramaniam Pennathur · 1×
Citations per year

Countries citing papers authored by Tom Teerlink

Since Specialization
Citations

This map shows the geographic impact of Tom Teerlink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Teerlink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Teerlink more than expected).

Fields of papers citing papers by Tom Teerlink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Teerlink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Teerlink. The network helps show where Tom Teerlink may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Tom Teerlink, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tom Teerlink Line = papers co-authored together Tom Teerlink links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201361
2 201268
3 201013
4 200928
5 200849
6 200831
7 200631
8 200628
9 2005124
10 200530
11 200427
12 200442
13 200327
14 200347
15 200339
16 200332
17 199713
18 199422
19 198712
20 19871

About Tom Teerlink

Tom Teerlink is a scholar working on Clinical Biochemistry, Physiology and Biochemistry, having authored 242 papers that have together received 10.1k indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (65 papers), Folate and B Vitamins Research (25 papers), Metabolism and Genetic Disorders (18 papers), Neuroscience of respiration and sleep (18 papers), Renin-Angiotensin System Studies (17 papers), Antioxidant Activity and Oxidative Stress (17 papers), Advanced Glycation End Products research (14 papers) and Clinical Nutrition and Gastroenterology (13 papers). The work is most often cited by research in Clinical Biochemistry (1.1k citations), Physiology (3.2k citations) and Nephrology (804 citations). Tom Teerlink has collaborated with scholars based in Netherlands, United States and Sweden. Frequent co-authors include P Scheffer, Paul A.M. van Leeuwen, Coen D.A. Stehouwer, Robert J. Nijveldt, Casper G. Schalkwijk, Sigrid de Jong, Robert J. Heine, Joost Dekker, Roger K. Schindhelm and Fredrik Palm. Their work appears in journals such as Atherosclerosis, Metabolism, Clinical Chemistry, Clinical Science and Hypertension.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026